CRAT links cholesterol metabolism to innate immune responses in the heart

Area of Science:

• Cardiology
• Molecular Biology
• Immunology

Background:

• Chronic inflammation is a key factor in heart failure development and prognosis.
• The exact mechanisms driving sustained inflammation in failing hearts are not fully understood.

Purpose of the Study:

• To elucidate the role of carnitine acetyltransferase (CRAT) in cardiac inflammation and heart failure.
• To investigate the link between cholesterol metabolism, innate immunity, and heart function in cardiomyocytes.

Main Methods:

• Investigated the impact of CRAT depletion on cholesterol catabolism and bile acid synthesis in cardiomyocytes.
• Analyzed mitochondrial DNA stress and cGAS-STING-dependent type I interferon responses.
• Assessed AIM2 inflammasome activation and its role in CRAT-deficient mice.
• Utilized genetic deletion models in mice to study myocardial inflammation and dilated cardiomyopathy.

Main Results:

• CRAT depletion promotes cholesterol breakdown via bile acid synthesis in cardiomyocytes.
• Accumulated bile acids induce mitochondrial DNA stress and cGAS-STING-mediated interferon responses.
• CRAT deficiency leads to increased AIM2 expression and inflammasome activation.
• Genetic CRAT deletion in mice causes myocardial inflammation and dilated cardiomyopathy, reversible by targeting caspase-1, cGAS, or AIM2.

Conclusions:

• A novel pathway links cardiac energy metabolism, cholesterol homeostasis, and innate immunity through CRAT-mediated bile acid synthesis.
• This pathway contributes to chronic myocardial inflammation and heart failure progression.
• Targeting CRAT or downstream immune responses may offer therapeutic strategies for heart failure.